Effect of bubble PEP on vital parameters in hospitalized COPD patients-an experimental study
Keywords:
COPD, vital parameters, PEP, bubble PEP, exacerbationAbstract
Chronic bronchitis and emphysema are included in the group of illnesses known as Chronic Obstructive Pulmonary Disease (COPD). Breathing becomes more difficult with COPD with time. Although lung damage cannot be reversed, lifestyle adjustments and medication adjustments can help to manage the symptoms. It is seen most frequently in adults all over the world and which has a negative impact on the patients' quality of life as it relates to their health, presents a significant obstacle for medical professionals and other health care workers. The biggest cause of death throughout the world is COPD. The prognosis of COPD patients may be improved by the management of functional and psychological deficits, as well as the reduction of activity restrictions. According to the new GOLD recommendations that has released in 2020, the goal focuses on the symptomatic treatment of COPD and the reduction of the risk of adverse health events that will have an effect on COPD patients over the long run in the form of exacerbations. In this paper we studied an effect of bubble PEP on vital parameters in hospitalized COPD patients. The data collection was done through sample collection techniques.
Downloads
References
Anders Bjerg, Jonas Eriksson, Inga Sif O´lafsdo´ttir, Roelinde Middelveld, Karl Franklin, Bertil Forsberg, Kjell Larsson, Kjell Tore´n, Sven-Erik Dahle´n and Christer Janson. “The association between asthma and rhinitis is stable over time despite diverging trends in prevalence”, 2015, Respiratory Medicine (2015) 109, 312e319, ELSEVIER.
Amir Qaseem, Timothy J. Wilt, Steven E. Weinberger, Nicola A. Hanania, Gerard Criner, Thys van der MolenDarcy D. Marciniuk, Tom Denberg, Holger Schu¨ nemann, Wisia Wedzicha, Roderick MacDonald and Paul Shekelle. “Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society”, 2011,
Christian R Osadnik, Christine F McDonald, Belinda R Miller, Catherine J Hill, Ben Tarrant, Ranjana Steward, Caroline Chao, Nicole Stodden, Cristino C Oliveira, Nadia Gagliardi and Anne E Holland. “The effect of positive expiratory pressure (PEP) therapy on symptoms, quality of life and incidence of re-exacerbation in patients with acute exacerbations of chronic obstructive pulmonary disease: a multicentre, randomised controlled trial”, 2013,
Giorgia Patrizio, Michele D’Andria, Francesco D’Abrosca, Antonella Cabiaglia, Fabio Tanzi, Giancarlo Garuti and Antonello Nicolini. “Airway Clearance with Expiratory Flow Accelerator Technology: Effectiveness of the “Free Aspire” Device in Patients with Severe COPD”, 2019,
A Aliverti, N Stevenson, R L Dellaca`, A Lo Mauro, A Pedotti and P M A Calverley. “Regional chest wall volumes during exercise in chronic obstructive pulmonary disease”, 2003,
B.R. Celli, R.J. Halbert, S. Isonaka and B. Schau. “Population impact of different definitions of airway obstruction”, 2003,
Tamara Schikowski, Dorothea Sugiri, Ulrich Ranft, Ulrike Gehring, Joachim Heinrich, H-Erich Wichmann and Ursula Krämer. “Long-term air pollution exposure and living close to busy roads are associated with COPD in women”, 2005,
Denis E O’Donnell, Paul Hernandez, Alan Kaplan, Shawn Aaron, Jean Bourbeau, Darcy Marciniuk, Meyer Balter, Gordon Ford, Andre Gervais, Yves Lacasse, Francois Maltais, Jeremy Road, Graeme Rocker, Don Sin, Tasmin Sinuff and Nha Voduc. “Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2008 update – highlights for primary care”, 2008,
Jayson C.J., Vaishnavi G., Tharani G., Kamatchi K. and Kirupa K. “To Compare the Effects of Acapella and Diaphragmatic Breathing Exercise in COPD Patients”, 2018,
Monika Fagevik Olsén and Elisabeth Westerdahl. “Positive Expiratory Pressure in Patients with Chronic Obstructive Pulmonary Disease – A Systematic Review”, 2008,
Mohamed Shamakh, Nagwa Badr, Mohamed El-Batanouny and Mohamed Shendy. “Acapella versus hand-held positive expiratory pressure on Pulmonary functions in management of chronic obstructive pulmonary diseases”, 2020,
ANNEMIE M. w. J. SCHOLS, PETER B. SOETERS, ANNEMARIE M. C. DINGEMANS, ROB MOSTERT, PETER J. FRANTZEN and EMIEL F. M. WOUTERS. “Prevalence and Characteristics of Nutritional Depletion in Patients with Stable COPD Eligible for Pulmonary Rehabilitation”, 1993,
Brigitte Eastwood, Nicola Jepsen, Katie Coulter, Conroy Wong and Irene Zeng. “Challenges of undertaking a clinical trial using bubble-PEP in an acute exacerbation of chronic obstructive pulmonary disease: A feasibility study”, 2017,
Bernd Lamprecht, Mary Ann McBurnie, William M. Vollmer, Gunnar Gudmundsson, Tobias Welte, Ewa Nizankowska-Mogilnicka, Michael Studnicka, Eric Bateman, Josep M. Anto, Peter Burney, David M. Mannino and Sonia A. Buist. “COPD in Never Smokers Results From the Population-Based Burden of Obstructive Lung Disease Study”, 2011,
Graciela E. Silva, Duane L. Sherrill, Stefano Guerra and Robert A. Barbee. “Asthma as a Risk Factor for COPD in a Longitudinal Study”, 2004,
Raquel Marçôa, Daniela Marta Rodrigues, Margarida Dias, Inês Ladeira, Ana Paula Vaz, Ricardo Lima and Miguel Guimarães. “Classification of Chronic Obstructive Pulmonary Disease (COPD) according to the new Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2017: Comparison with GOLD 2011”, 2018,
Ana M Menezes, Fernando C Wehrmeister, Rogelio Perez-Padilla, Karynna P Viana, Claudia Soares, Hana Müllerova, Gonzalo Valdivia, José R Jardim and Maria Montes de Oca. “The PLATINO study: description of the distribution, stability, and mortality according to the Global Initiative for Chronic Obstructive Lung Disease classification from 2007 to 2017”, 2017,
Yu-He Hu, Zhen-Yu Liang, Li-Mei Xu, Wen-Hui Xu, Hao Liao, Rui Li, Kai Wang, Ying Xu, Chun-Quan Ou and Xin Chen. “Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China”, 2018,
Stephen Milan, Praveen Bondalapati, Michael Megally, Eshan Patel, Pramil Vaghasia, Liam Gross, Elizabeth M Bachman, Puja Chadha and Jeremy A Weingarten. “Positive Expiratory Pressure Therapy With and Without Oscillation And Hospital Length Of Stay For Acute Exacerbation Of Chronic Obstructive Pulmonary Disease”, 2019,
Ruth Barker, Anthony A Laverty and Nicholas S Hopkinson. “Adjuncts for sputum clearance in COPD: clinical consensus versus actual use”, 2017.
Published
How to Cite
Issue
Section
Copyright (c) 2023 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
